Home Medicines Services to support the response to COVID-19
On 11 March 2020, the Prime Minister, the Hon. Scott Morrison MP, announced a $2.4 Billion health plan to fight COVID-19 to protect all Australians, including vulnerable groups such as the elderly, those with chronic conditions and Indigenous communities, from the coronavirus (COVID-19).
“The Government will provide $25 million to fund home medicines services which will enable patients to have their PBS prescriptions filled online or remotely, and have the medicines delivered to their home.
This service will be available for people in home isolation and for vulnerable patient groups.”
What is the Home Medicines Service?
To protect the Australian community from exposure to novel coronavirus (COVID‑19), the Australian Government is implementing a time limited service to support the delivery of Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme (RPBS) medicines products to people in their homes.
From 16 March 2020, a fee per delivery will be payable to Australian pharmacies providing an eligible medicines home delivery to eligible patients.
Eligible patients include vulnerable people and people in home isolation with a confirmed or suspected COVID-19 infection.
Vulnerable people and people in self isolation will be able to order their Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme (RPBS) prescriptions remotely and have their medicines home delivered to reduce their potential exposure to COVID-19.
Why is this important?
This temporary measure will protect the most vulnerable members of our community and is available to:
- people isolating themselves at home on the advice of a medical practitioner, in accordance with home isolation guidance issued by the Australian Health Protection Principle Committee for confirmed COVID-19 cases,
- people who meet the current national triage protocol criteria for suspected COVID-19 infection after consultation with either the national COVID-19 hotline, state COVID-19 hotlines, a registered medical or nursing practitioner, or COVID-19 trained health clinic triage staff
- people aged over 70
- Aboriginal and Torres Strait Islander people aged over 50
- people with chronic health conditions or who are immunocompromised
- parents with new babies and people who are pregnant.
This measure complements the expanded use of telehealth under Medicare, and the proposed development sprint with the software industry to make electronic prescribing more widely available in eight weeks.
At present, electronic prescribing and dispensing capability is developing in Australia, but is not widely available. Some pharmacy chains currently support remote dispensing of prescriptions using a combination of mailed prescriptions, faxed/emailed prescriptions or electronic transfer of prescriptions (ETP) technology.
This is an optional, demand-driven service, temporarily available for six months.
All community pharmacies will be eligible to participate if they can support online dispensing of medicine and provide home delivery services. The Government will be working quickly with pharmacies to roll out this capability.
Vulnerable people in the community, including those in self isolation, will be able to order and receive their PBS/RPBS medicines at home.
Resource(s):Australian Government, Department of Health: https://www.health.gov.au/resources/publications/covid-19-national-health-plan-primary-care-home-medicines-services-to-support-the-response-to-covid-19Australian Government, Prime Minister of Australia, Media release, 11 March 2020: https://www.pm.gov.au/media/24-billion-health-plan-fight-covid-19
What is accessible design?
Find out about what accessible design is and about the Accessible Design Division.
Advocacy & policy
Arthritis Australia advocates to government, business, industry and community leaders to improve care, management, support and quality of life for people with arthritis.
10 steps for living well with arthritis
Here is our 10 steps checklist to help you live with arthritis.
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: